ABBV insider transactions
AbbVie Inc. (ABBV) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
ABBV insiders
Everyone who has filed a Form 3, 4, 5 or 144 at AbbVie Inc., latest first. Follow anyone to get their next filing.
- Edward J RappDirector
- Susan E QuagginDirector, since October 2023
- Nicholas DonoghoeEVP, Chief Bus/strat Officer, since June 2023-$15M
- Robert J AlpernDirector
- Thomas J FalkDirector, since May 2025
- Rebecca B RobertsDirector
- Thomas C FreymanDirector
- Melody B MeyerDirector
- Frederick H WaddellDirector
- Jennifer L. DavisDirector, since October 2023
- Brett J HartDirector
- William H.l. BurnsideDirector
- Roxanne S AustinDirector-$10.8M
- David Ryan PurdueSVP, Controller, since March 2025-$1.22M
- Demetris D CrumEVP, Chief Hr Officer, since July 2025
- Roopal ThakkarEVP, R&D and CSO, since December 2023
- Robert A. MichaelChairman of the Board and CEO, Director-$18.5M
- Azita Saleki-GerhardtEVP, Chief Operations Officer-$37.2M
- Jeffrey Ryan StewartEVP, Chief Commercial Officer-$40.4M
- Perry C SiatisEVP, GC and Secretary, since October 2022-$24.2M
- Scott T ReentsEVP, Chief Financial Officer, since June 2022-$8.7M
- Richard A GonzalezExecutive Chairman of Board, Director-$158M
- AbbVie Inc.EVP, Chief HR Officer, since July 2025
- Glenn F TiltonDirector
- Kevin K BuckbeeSVP, Controller, since March 2023-$5.07M
- Timothy J. RichmondEVP, Chief Hr Officer-$45.8M
- Thomas J HudsonSVP, Cso, Global Research
- Carrie C StromOfficer-$5.73M
- Elaine K. SorgOfficer-$15.6M
- Brian L DurkinOfficer-$4.31M
- Michael SeverinoOfficer-$88.2M
- Henry O GosebruchOfficer-$35.6M
- Edward M LiddyDirector
- Laura J SchumacherOfficer-$23.7M
Recent Form 3, 4, and 5 filings for ABBV
- SEC Form 3 filed by AbbVie Inc.3 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Director Rapp Edward J4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Director Quaggin Susan E4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas sold $8,177,500 worth of shares (32,710 units at $250.00) and exercised 32,710 shares at a strike of $79.02 (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Director Rapp Edward J4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Director Quaggin Susan E4 - AbbVie Inc. (0001551152) (Issuer)
- Director Falk Thomas J was granted 1,118 shares, increasing direct ownership by 93% to 2,321 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Quaggin Susan E was granted 1,118 shares, increasing direct ownership by 44% to 3,643 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Rapp Edward J was granted 1,118 shares, increasing direct ownership by 2% to 45,964 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Meyer Melody B was granted 1,118 shares, increasing direct ownership by 7% to 17,616 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Freyman Thomas C was granted 1,118 shares, increasing direct ownership by 0.88% to 127,869 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Roberts Rebecca B was granted 1,118 shares, increasing direct ownership by 8% to 14,846 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Hart Brett J was granted 1,118 shares, increasing direct ownership by 6% to 20,590 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Davis Jennifer L. was granted 1,118 shares, increasing direct ownership by 44% to 3,643 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Waddell Frederick H was granted 1,118 shares, increasing direct ownership by 4% to 30,076 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Austin Roxanne S was granted 1,118 shares, increasing direct ownership by 3% to 39,576 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Burnside William H.L. was granted 1,118 shares, increasing direct ownership by 4% to 28,076 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Rapp Edward J4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Alpern Robert J4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Quaggin Susan E4 - AbbVie Inc. (0001551152) (Issuer)
- Amendment: SEC Form 4/A filed by AbbVie Inc.4/A - AbbVie Inc. (0001551152) (Issuer)
- SVP, Controller Purdue David Ryan sold $1,221,519 worth of shares (5,230 units at $233.56), decreasing direct ownership by 66% to 2,654 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF HR OFFICER Crum Demetris D covered exercise/tax liability with 1,594 shares, decreasing direct ownership by 17% to 7,914 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, R&D and CSO Thakkar Roopal covered exercise/tax liability with 8,037 shares, decreasing direct ownership by 13% to 52,376 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- CHAIRMAN OF THE BOARD AND CEO Michael Robert A. covered exercise/tax liability with 36,523 shares, decreasing direct ownership by 17% to 178,737 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF FINANCIAL OFFICER Reents Scott T covered exercise/tax liability with 21,638 shares, decreasing direct ownership by 36% to 38,777 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas covered exercise/tax liability with 12,874 shares, decreasing direct ownership by 15% to 74,430 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF OPERATIONS OFFICER Saleki-Gerhardt Azita covered exercise/tax liability with 16,309 shares, decreasing direct ownership by 8% to 197,794 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, GC AND SECRETARY Siatis Perry C covered exercise/tax liability with 14,850 shares and sold $4,375,549 worth of shares (18,668 units at $234.39), decreasing direct ownership by 88% to 4,619 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- SVP, Controller Purdue David Ryan covered exercise/tax liability with 2,692 shares, decreasing direct ownership by 25% to 7,884 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF COMMERCIAL OFFICER Stewart Jeffrey Ryan covered exercise/tax liability with 23,812 shares, decreasing direct ownership by 22% to 83,171 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, GC AND SECRETARY Siatis Perry C exercised 22,381 shares at a strike of $172.62 and sold $5,147,630 worth of shares (22,381 units at $230.00) (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, R&D and CSO Thakkar Roopal was granted 18,137 shares, increasing direct ownership by 43% to 60,413 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF COMMERCIAL OFFICER Stewart Jeffrey Ryan was granted 53,749 shares, increasing direct ownership by 101% to 106,983 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, GC AND SECRETARY Siatis Perry C was granted 33,518 shares, increasing direct ownership by 726% to 38,137 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- SVP, Controller Purdue David Ryan was granted 6,071 shares, increasing direct ownership by 135% to 10,576 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas was granted 29,057 shares, increasing direct ownership by 50% to 87,304 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF OPERATIONS OFFICER Saleki-Gerhardt Azita was granted 36,811 shares, increasing direct ownership by 21% to 214,103 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF HR OFFICER Crum Demetris D was granted 2,460 shares, increasing direct ownership by 35% to 9,508 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF FINANCIAL OFFICER Reents Scott T was granted 48,838 shares, increasing direct ownership by 422% to 60,415 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- CHIEF EXECUTIVE OFFICER Michael Robert A. was granted 82,439 shares, increasing direct ownership by 62% to 215,260 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Director Quaggin Susan E4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Director Alpern Robert J4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Director Rapp Edward J4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Director Quaggin Susan E4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Director Alpern Robert J4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Director Rapp Edward J4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF OPERATIONS OFFICER Saleki-Gerhardt Azita sold $8,407,055 worth of shares (42,370 units at $198.42) and exercised 42,370 shares at a strike of $54.86 (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas sold $2,639,253 worth of shares (13,295 units at $198.51), decreasing direct ownership by 19% to 58,247 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Amendment: New insider Crum Demetris D claimed ownership of 7,048 shares (SEC Form 3)3/A - AbbVie Inc. (0001551152) (Issuer)
- New insider Abbvie Inc. claimed ownership of 7,048 shares (SEC Form 3)3 - AbbVie Inc. (0001551152) (Reporting)
- SEC Form 4 filed by Director Quaggin Susan E4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Director Rapp Edward J4 - AbbVie Inc. (0001551152) (Issuer)
- SEC Form 4 filed by Director Alpern Robert J4 - AbbVie Inc. (0001551152) (Issuer)
- Director Falk Thomas J was granted 1,203 shares (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Freyman Thomas C was granted 1,203 shares, increasing direct ownership by 0.96% to 126,751 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Tilton Glenn F was granted 1,203 shares, increasing direct ownership by 2% to 51,564 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Waddell Frederick H was granted 1,203 shares, increasing direct ownership by 4% to 28,958 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Roberts Rebecca B was granted 1,203 shares, increasing direct ownership by 10% to 13,728 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)
- Director Hart Brett J was granted 1,203 shares, increasing direct ownership by 7% to 19,472 units (SEC Form 4)4 - AbbVie Inc. (0001551152) (Issuer)